Interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF␣) are proinflammatory cytokines that are constitutively expressed in healthy, adult brain where they mediate normal neural functions such as sleep. They are neuromodulators expressed by and acting on neurons and glia. IL-1 and TNF␣ expression is upregulated in several important diseases/disorders. Upregulation of IL-1 and/or TNF␣ expression, elicited centrally or systemically, propagates through brain parenchyma following specific spatio-temporal patterns. We propose that cytokine signals propagate along neuronal projections and extracellular diffusion pathways by molecular cascades that need to be further elucidated. This elucidation is a prerequisite for better understanding of reciprocal interactions between nervous, endocrine and immune systems. Molecular Psychiatry (2000) 5, 604-615.
Introduction
Interleukin-1 (IL-1) and tumor necrosis factor ␣ (TNF␣) are major proinflammatory cytokines quickly released and synthesized in response to infections. Cytokines are intercellular messengers first discovered in the immune system where they integrate activities of several cell types in different body compartments into a coherent immune response. IL-1 (and its receptors) is the first cytokine detected in the brain. [1] [2] [3] [4] The presence of IL-1 and its receptors in the brain implied that it might act there. Indeed, IL-1 injected into the brain of rats induced conditioned taste aversion 5 and suppressed feeding. 6 IL-1␤ was induced in brain macrophages and microglia after intravenous (iv) injections of lipopolysacharide (LPS) indicating that systemic signals regulate IL-1 expression in the brain. 7 LPS (iv)-induced IL-1 upregulation was proposed and later proven to cause non-specific sickness symptoms. Sickness, 8 fever, 9,10 anorexia, 11 hyperalgesia 12 and changes in the hypothalamic-pituitary adrenal (HPA) axis 13 are all mediated by IL-1 and/or TNF␣ actions in the brain. This has popularized a view that these cytokines are immunomodulators in the brain, expressed and acting only in diseases. However, extensive analysis of published data argues that IL-1 and TNF␣ are also neuromodulators acting in normal, healthy, adult brain. 14 This is based on four lines of evidence. IL-1␣, IL-␤ and TNF␣ mRNAs and proteins, accessory proteins involved in regulation of their activity and their receptors are all present in normal adult brain. They modulate neuronal functions from electrophysiological activity to gene expression. Conversely, neuronal activity controls their production in the brain. They modulate several autonomic and behavioral processes subserved by central neurons.
Expression of IL-1 and TNF␣ genes is upregulated in the brain in disease. At least eight major diseases/disorders of the brain, occurring chronically (eg Alzheimer's disease) or instantaneously (epilepsy), elicited centrally (audiogenic seizure) or systemically (HIV-1 infection) are associated with upregulation in IL-1 and TNF␣ expression ( Table 1 ). The upregulation is not confined to the regions of neuropathology. For example, IL-1 is elevated in cortex of individuals who died with AIDS 15 although the frequency of HIV-1-infected cells in the cortex is lower than in other regions. 16 Evidence reviewed here indicates that both central and systemic perturbations induce or upregulate IL-1 and TNF␣ expression and this 'cytokine signal' propagates through the parenchyma sometimes to distant regions that are apparently unconnected by neu- 17 (By 'perturbations' we mean central or systemic stimuli that alter IL-1 and TNF␣ expression.) We sought to identify the mechanism and pathways (ie physical substrates) of cytokine signal propagation within the brain. By 'propagation' we mean intra-and extracellular molecular changes that occur in a spatio-temporal order and result in upregulation/induction of IL-1 and/or TNF␣. We propose here that the cytokine signals propagate along neuronal projections and extracellular diffusion pathways and that the molecular cascades transmit and may modify the intensity of the original signal.
Two examples of upregulation of IL-1 and TNF␣ expression: AIDS and epilepsy
IL-1 and TNF␣ expression is upregulated in the brain in neurodegenerative diseases, ischemia, trauma, inflammation, epilepsy and infections such as with HIV-1 ( Table 1) . In AIDS, IL-1 and TNF␣ expression is upregulated in all brain regions thus far examined. 18 Their upregulation in the cortex, where HIV-1 load is low, suggests that the cytokine signal propagates from other brain regions, possibly those where HIV-1 load is high. We proposed that the upregulation of IL-1 and TNF␣ in AIDS brain is caused by circulating IL-1. 18 IL-1 and other cytokines are elevated in circulation during the initial, acute phase of HIV-1 infection and likely play a role in the development of clinical manifestation of AIDS. 19 Circulating IL-1␤ induces another cytokine, TGF-␤1, in astrocytes at the blood-brain barrier (BBB). 18 TGF-␤1 is a potent attractant for monocytes/macrophages 20 and may recruit HIV-1-infected macrophages to enter brain parenchyma. 21, 22 Later, IL-1 produced by both HIV-1-infected macrophages and reactive microglia likely induces IL-1 synthesis in neural cells. 23, 24 A cytokine casacade that ensues may look like this: circulating IL-1 → ⊕ → brain IL-1 and TNF␣ ↑ → propagation of the cytokine signal through the brain → → ⊕ → HIV-1-infected cells entry into parenchyma ↑
22,23
→ ⊕ → Astrocytosis ↑ 25 → ⊕ → HIV-1 load ↑.
26
Central stimuli can also upregulate IL-1 and TNF␣. IL-1␣ immunoreactivity (ir) increases and IL-1␣ producing cells are three times as numerous in surgically resected tissue from the temporal lobe of patients with intractable epilepsy as compared to controls. 27 Epileptogenic seizures can be induced in rodents by injecting kainate or penicillin into hippocampus or amygdala or by exposing genetically susceptible mice to sound of a certain frequency. Audiogenic seizures increase IL-1␣ mRNA in hypothalamus, but not hippocampus, in 6-8 h. 28 IL-1␤ ir increases Х 16-fold, 24 h after a unilateral injection of kainate, in both injected and contralateral hemispheres. 29 Exogenous IL-1␤ prolongs kainateinduced seizures and IL-1 receptor antagonist (Ra) abrogates the effect. Seizures induced by kainate injections into amygdala result in Х 12-fold upregulation of Molecular Psychiatry TNF␣ ir in both hippocampal hemispheres in 2 days. 30 These data indicate that epileptic seizures upregulate IL-1 and TNF␣ expression. Thus, upregulation of IL-1/TNF␣ expression may be elicited both systemically or centrally as in AIDS and epilepsy, respectively.
Cytokine signals propagate through the brain
Epileptic seizures consist of sustained activity of discreet neuronal populations. When the seizures are elicited by kainate injections into hippocampus or amygdala, they propagate to distant brain areas connected by neuronal projections. 31 The propagation creates a well-defined spatio-temporal pattern that can be discerned by cerebral blood flow or glucose metabolism: ipsilateral → contralateral hippocampus ↔ amygdala → the rest of the limbic system → striatum → sensory motor cortex → lower brain centers → thalamus → septum → parietal cortex. 32 In contrast, seizures elicited by injection of penicillin into cortex or hippocampus propagate no further than ipsilateral thalamus. 33 Thus, epileptic seizures propagate through the brain and the propagation patterns depend, at least in part, on where they originated. Since epileptogenic seizures upregulate cytokine expression, do cytokine signals propagate with seizure activity? Unfortunately, this question has not yet been addressed. However, cytokine signal propagation has been investigated after both central and systemic stimuli: a unilateral surgical lesion to the hippocampus and an intraperitonial (ip) injection of LPS. Whereas the latter models systemic infections such as with HIV, the former does not model epileptic seizures.
Centrally elicited cytokine signaling
Because the hippocampus is particularly epileptogenic and highly sensitive to injuries, 34 we used a surgical lesion to mouse hippocampus to elicit the cytokine upregulation and analyze its propagation pattern. IL-1␣ and TNF␣ are induced in neurons after a surgical lesion to the right hemisphere and their expression propagates to various regions of the brain in a spatiotemporal pattern. 35 Twenty-four hours after the lesion, intense IL-1␣ and TNF␣ ir appears in the striatum in the right hemisphere, ie, at a distance from the lesion (Figure 1a and b) but, not in the hippocampus itself. IL-1R density decreases, IL-1Ra mRNA level strongly increases and IL-1 (␣ and ␤) mRNA levels remain unchanged around the lesion. 36 The levels return to normal 7 days after the lesion. Three to 5 days after the lesion, IL-1 and TNF␣ ir increase and spread to the ipsilateral frontal cortex and thalamus and, after 6 days, to the contralateral frontal cortex, thalamus and striatum. At the peak of expression, 9-12 days after the lesion, the expression extends to the rest of the cortex (Figure 1d and e), basal ganglia (Figure 1g and h) , cerebellum, hippocampus, amygdala, diagonal band of Broca, substantia nigra, hypothalamus and raphe. 37 These data suggest that the IL-1 signal consists of changes in concentration of specific IL-1 family members. The changes are transient and timed to provide IL-1 action in a specific spatio-temporal pattern. The surgical lesion-elicited spatio-temporal pattern of IL-1␣ and TNF␣ ir propagation is reminiscent of the propagation of epileptic seizure activity of hippocampal origin. 32, 38, 39 In contrast, surgical lesions to other regions, such as striatum or cortex, fail to raise such distal activation. Thus, propagation of cytokine signals, like epileptogenic seizure activity, depends on where in the brain they originate. IL-1␣ and TNF␣ are synthesized by those neurons where the ir is detected, as judged by detection of their mRNA in situ (eg Figure 1i) . 35 This suggests that the cytokines remain cell-bound rather than diffuse to activate distant cells.
An immediate early gene (IEG) product, c-Fos, ir appears several days before the cytokines at the site of the injury in the hippocampus rather than striatum. 40 C-Fos is expressed in most, although not all (cortex, cerebellum, and raphe) regions where cytokines are later expressed. C-Fos is not expressed in distal neurons after surgical lesions to other brain regions. Similarly, seizures originating in the cortex induce c-Fos and c-Jun (another IEG product) in the epileptic focus and neither in contralateral cortex nor ipsilateral thalamus. 33 Spatial patterns of injury and seizure-induced c-Fos expressions appear similar to each other. [38] [39] [40] CFos binds c-Jun to form activation factor-1 (AP-1), a transcription factor, which induces/upregulates the expression of IL-1, TNF␣ and other genes. This suggests that AP-1 could initiate cytokine signals in neurons after some central perturbations. Surgical lesioninduced cytokine signal apparently propagates in the absence of cytokine expression in glial cells. 35 However, glial cells may also initiate cytokine signal propagation after some central perturbations. For example, A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] injected into amygdala increases IL-1␤ ir first in microglia of the amygdala and later in distant hippocampal neurons. 41 This suggests that cell types propagating cytokine signals vary with the nature of the perturbation eliciting the signal.
IL-1 and TNF␣ upregulate cyclooxygenase2 (COX2) and nitric oxide synthases (NOS), the enzymes synthesizing second messengers prostaglandins and nitric oxide, respectively. The induction is mediated by transcription factor nuclear factor B (NF-B), a regulator of many inflammatory and immune genes' expression. 42, 43 Its activity is regulated by the inhibitory factor I-B, of which the mRNA induction has been used as a marker of NF-B activation. Thus, COX2 and inducible NOS (iNOS) are assayed as readouts of cytokine activity. iNOS appears in hippocampal pyramidal and granular neurons, astrocytes and microglial cells, 2 days after hippocampal surgical lesion. 44 Its activity is detected in only a few interneurons in the controls. By comparison, surgical lesions to the prefrontal or cerebellar cortex induce iNOS activity only in monocyte/macrophage-like cells confined to a small area around the lesion. Thus, the spatio-temporal patterns of iNOS and IL-1␣ expressions do not correspond to each other, 35, 44 suggesting that IL-1␣ does not induce iNOS after hippocampal surgical lesion.
Systemically elicited cytokine signaling
It is now well established that pro-inflammatory cytokines act upon the central nervous system during peripheral inflammation to induce fever, activation of the HPA axis and sickness. 45 However, it is not at all clear how cytokines do so, since the brain is protected by the BBB preventing entry of large hydrophilic molecules, such as IL-1 and TNF␣. Peripheral injection of bacterial LPS resulting in the endogenous release of IL-1 and TNF␣ or administration of exogenous IL-1 and TNF␣ induces cellular activation markers such as cFos and I-B mRNA, at the BBB.
46,47 C-Fos is rapidly activated after many different stimuli, including IL-1␤. Therefore, detection of c-Fos mRNA or protein may reveal target cells for IL-1␤ or cells that propagate this signal. Intravenous injection of IL-1␤ in rats causes two waves of cellular activation at the BBB. 46 The first wave of c-Fos mRNA induction occurs at the blood side of the BBB 30 min after IL-1␤ injection and probably reflects the action of circulating IL-1␤ on its receptors present on blood vessel associated-cells. [48] [49] [50] The second wave of cellular activation occurs 3 h after IL-1␤ administration at the parenchymal side of the BBB in perivascular microglia and astrocytes and is assumed to be mediated by messengers that are induced by IL-1␤ and cross the BBB. 46 Systemic injecMolecular Psychiatry tion of LPS or IL-1 and TNF␣ results in induction of the alpha subunit of I-B mRNA 47 as well as COX2, iNOS and IL-1␤ mRNA in brain endothelial cells. [51] [52] [53] This suggests that prostaglandins and nitric oxide (NO) induced by IL-1 and TNF␣ propagate the IL-1 and TNF␣ message and cause c-Fos mRNA expression in the perivascular microglia and astrocytes on the parenchymal side of the BBB. 46 In contrast to the rather limited activation around blood vessels making up the BBB, a more important spread of cellular activation occurs away from circumventricular organs (CVOs) and invades the adjacent parenchyma over time in response to peripheral injection of IL-1␤ or LPS. 46, 54, 55 The blood vessels in CVOs lack a functional BBB. Therefore, molecules up to 500 kDa, including IL-1, can be found in these organs after iv injection. 56, 57 Moreover, cells in CVOs express I-B and IL-1␤ mRNA after injection of low doses of LPS which do not induce these mRNAs at the BBB. 58 This indicates that the source of a peripheral IL-1 and TNF-␣ signal propagation is predominantly at the level of CVOs. At later time points after peripheral LPS injection, iNOS mRNA expression is found at the edge of CVOs together with a second wave of IL-1␤ induction in microglia of the parenchyma adjacent to CVOs (Figure 2) . 55 These data can be interpreted to suggest that IL-1␤ in CVOs diffuses into the brain parenchyma and propagates its message by inducing its own synthesis in microglia.
Lesion and pharmacological intervention studies support the importance of CVOs in the effects of IL-1␤ on the brain. Large lesions of the organum vasculosum of the laminae terminalis (OVLT), the CVO of the anterior hypothalamus, prevent fever in response to peripheral LPS. 59, 60 Moreover, injection of IL-1Ra or prostaglandin or NO synthesis inhibitors into the OVLT attenuates IL-1␤-induced fever, 61 indicating that prostaglandins and NO produced in the OVLT are important in propagating the IL-1␤ message to induce fever. Similarly, lesions of the area postrema, a CVO in the brainstem, block activation of CRH neurons of the PVN in response to intravenously administered IL-1␤. 62 The ependymal cell layer lining two other CVOs, the median eminence and area postrema, does not form a tight blood-cerebrospinal fluid (CSF) barrier. [63] [64] [65] This implies that cytokines synthesized and released in these CVOs have access to ventricular CSF. In accordance with this prediction, bioactive IL-1 appears in ventricular CSF after peripheral IL-1 or LPS injection. 66, 67 When mimicking the presence of IL-1␤ in CSF by intracerebroventricular injection of a dose of IL-1␤ that induces fever, the HPA axis is activated, sickness ensues, and NF-B is activated in the cells lining the ventricle (Konsman, unpublished observations). However, IL-1␤ concomitantly appears in the basolateral amygdala, where neuronal IL-1 receptors are present. 49, 50 This indicates that IL-1␤ released from the median eminence into the ventricular CSF might activate cells in distant brain structures. This hypothesis was subsequently tested by blocking, with the IL-1 Ra administered into the lateral ventricle, the action of endogenous ventricular IL-1 in rats injected systemically with LPS. This treatment prevented c-Fos induction in the amygdala and attenuated sickness (Konsman, unpublished observations). These findings confirm that the IL-1␤ signal in the ventricular CSF after peripheral LPS injection propagates to the amygdala.
In summary, the IL-1 and TNF␣ messages originating from the periphery propagate into the central nervous system at several levels. Circulating IL-1 and TNF␣ induce diffusible messengers, such as prostaglandins and NO, in blood vessel associated cells and these mediators may help to propagate the cytokine message beyond the BBB. For example, after infection with Vesicular Stomatitis Virus, iNOS KO mice have an intact BBB whereas neuronal NOS KO and wild-type strains have a damaged BBB. 68 This indicates that iNOS affects the integrity and therefore function of the BBB. NO could mediate propagation of cytokine signals wherever in the brain. However, the spread of cellular activation is much more important at the level of CVOs, where the BBB is absent. In addition, cytokines induced in CVOs during peripheral inflammation and cytokines leaking from the blood vessels in the CVOs can access the ventricular CSF. Once in the CSF, cytokines are able to spread over long distances well beyond the parenchyma just behind the BBB.
IL-1 and TNF␣ in the CSF
IL-1 injected into the lateral ventricle to mimic the presence of IL-1␤ in CSF induces itself in cells of the meninges, the parenchyma surrounding the ventricles and nerve bundles of the corpus callosum (Konsman et al, unpublished observations). The IL-1␤ signal propagates in a pattern similar to that elicited by systemic injection of LPS: c-Fos is induced in the same brain regions as IL-1␤ and in neurons of the hypothalamus and the limbic system. 69 In addition, TNF␣ mRNA level increases and sickness ensues. Centrally delivered IL-1Ra abrogates these effects. 70 Together, these findings suggest that the ventricular IL-1␤ induces via IL-1R and/or AP-1, IL-1␤ and other cytokines' synthesis, a bona fide cytokines cascade. The IL-1␤ signal may also propagate by diffusion of IL-1␤ throughout the CSF. IL-1␤ concentration in CSF is high in AIDS, 71, 72 Alzheimer's disease, 73 multiple sclerosis, 74 bacterial infections 75 and trauma. 76 These data together indicate that centrally produced IL-1 and TNF␣ may be released into the CSF where they diffuse over distances far greater than the anterior hypothalamus. Thus, CSF may serve as one pathway of cytokine signal propagation.
Pathways of cytokine signal propagation
The precise pathways of cytokine signal propagation within the brain have not been characterized. Agnati et al defined two classes of pathways of signal propagation in the brain: volume transmission and wiring. 77 Wiring includes neuronal projections and gap junctions and volume transmission denotes signal diffusion within the brain extracellular fluid. Volume transmission and neuronal projections were previously proposed to mediate cytokine effects in and around the BBB. 54 The evidence reviewed here extends this proposal to cytokine signal propagation throughout the brain.
Propagation by diffusion through the CSF
Because the blood vessels in the CVO lack functional BBB, IL-1␤ (and other molecules up to 500 kDa in size) injected iv rapidly reaches these organs. 56, 57 This makes CVO an ideal pathway for the propagation of systemic signals into the brain parenchyma. Systemic LPS elicits fever at the level of the OVLT. 59, 60, 78 Fever response is mediated by cytokine cascade involving endogenous IL-1 in anterior hypothalamus, paraventricular nucleus (PVN), subfornical organ (SFO) and hippocampus but not in the ventromedial hypothalamus, OVLT, striatum or cortex. Ablation of the AP blocks activation of CRH neurons of the PVN that respond to IL-1␤ iv and abrogates the activation of the HPA axis 62 (also, see Ericsson et al for negative findings). 79 These data suggest that the propagation of some cytokine signals through the brain is by volume transmission. 77 Volume transmission utilizes CSF, nerve bundles and perivascular space. Perivascular space seems to conduct the spread of IL-1␤ from the CVO into the adjacent brain parenchyma after the systemic injection of LPS. 55 Proteins injected iv reach CVO but not the surrounding brain parenchyma. 57 IL-1 may get into the ventricular CSF from AP and median eminence because these areas lack tight blood-CSF barrier. [63] [64] [65] Indeed, bioactive IL-1 appears in CSF after ip injection of LPS. 67 Once in the CSF, it may diffuse by the flow generated by CSF production in the choroid plexus and absorption in the superior saggital sinus. The total volume of CSF turns over two to three times per day, 80 suggesting that cytokines can diffuse over very long distances within hours. In fact, 30-40% of TNF␣ injected into the lateral ventricle appears in aortic blood in 4 h. 81, 82 The appearance of cytokines in blood withdrawn from the aorta is preceded by their appearance in blood from the superior saggital sinus. This indicates that cytokines propagate by CSF flow. Cytokines can enter the parenchyma at distant sites, since horseradish peroxidase, a molecule much bigger than cytokines, rapidly enters parenchyma when Molecular Psychiatry injected into the lateral ventricle. 83 IL-1␤, IL-1Ra or Dextran 10 kDa infused into the lateral ventricle rapidly spread to the tissue immediately surrounding the lateral and third ventricle and around blood vessels in ventricles (Konsman, unpublished) . The fluid circulation in perivascular spaces constitutes a rapid anisotropic diffusion pathway in the brain 77 and may explain the presence of IL-1 around blood vessels after infusion into the lateral ventricle. Later, IL-1 diffuses from the lateral ventricle along the corpus callosum and external capsule as well as along the white matter nerve bundles of the striatum all the way into the amygdala (Konsman, unpublished) . The pattern of diffusion along nerve bundles suggests that an anisotropic diffusion pathway is in small channels located outside the myelinated axons. 77 This pathway is delineated by the distribution of the Dextran 10 kDa after local injection into the striatum. 84 Altogether, these data suggest that IL-1␤ first diffuses from CVO into the surrounding tissue by arteriolar pulsations (eg from median eminence to arcuate nucleus). IL-1␤ produced in the median eminence can also access the CSF because the blood-CSF barrier is leaky. From the CSF IL-1␤ enters distant brain parenchyma and propagates along nerve bundles and blood vessels to, for example, the amygdala.
The hypothesis that IL-1 diffuses with the CSF flow is supported by the following observations. IL-1␤ injected into the striatum, but not cortex, exacerbates excitotoxic damage in the cortex. 85, 86 This is likely due to its anisotropic diffusion through the ventricular CSF or perivascular space. Extracellular markers such as Dextran are rapidly removed from the striatum and accumulated around the lateral ventricle, 84, 87 suggesting that they spread into the CSF. However, injection of markers into the cortex rarely results in spread away from the site of injection. 88 Once in the CSF, IL-1␤ follows the CSF flow and accumulates in the subarachnoid space that is separated from cortical surface by the pial membrane. Although entry of some molecules into subpial space and cortical parenchyma from the subarachnoid space has been described, 57, 88 it is generally thought that the pial membrane effectively separates subarachnoid CSF and the cortical surface. 89 Systemic cytokine signals apparently propagate through the brain by several pathways (Figure 3 ). Circulating cytokines elicit a cascade of second messengers in blood vessel-associated cells and these messengers may propagate the cytokine signals across the BBB. However, the spread of cellular activation is much more important at the level of CVO, where the BBB is absent. In addition, cytokines induced in CVO during systemic inflammation and cytokines that enter from the blood stream seem to access ventricular CSF. Once in the CSF, they can spread over long distances and their messages propagate well beyond the parenchyma surrounding blood vessels.
Propagation via neuronal projections
The spatio-temporal propagation of neuronal IL-1␣ and TNF␣ expression after hippocampal lesion follows, in Molecular Psychiatry Figure 3 A schematic diagram showing putative pathways of IL-1␤ signal propagation after LPS injection (ip). IL-1␤ ir is detected in organum vasculosum of the lamina terminalis (OVLT), area postrema (AP), subfornical organ (SFO), median eminence (ME) and choroid plexus (ChP). IL-1␤ secreted in OVLT and AP may be conveyed by pulsations of the nearby arterioles to the adjacent ventromedial preoptic area (VMPO) and nucleus tractus solitarius (NTS), respectively, where it induces synthesis of itself and iNOS mRNA (dashed line). In AP, IL-1␤ may activate, via its receptors, the neurons that heavily project to the medial subdivision of NTS (full line). Lastly, IL-1␤ may enter ventricular CSF in AP and ME due to the leaky blood-CSF barrier there (dashed line).
part, mapped efferent and afferent neuronal projections (Figure 4 ). Hippocampal comissure also could be a pathway for the bilateral propagation of cytokine expression. In all these regions, most neurons are induced to express IL-1␣ and TNF␣. 35 All types of neu- Figure 4 A schematic diagram of a template for cytokine signal propagation pathways activated by a surgical lesion to the right hippocampal hemisphere. IL-1␣ and TNF-␣ immunoreactivities are detected in the following brain areas (× days after the lesion): striatum (1), ipsilateral (3-5) and contralateral thalamus and frontal cortex (6), the rest of cortex, hippocampus, diagonal band, substantia nigra, raphe, amygdala, basal ganglia, locus coeruleus, accumbens and cerebellum (9) (10) (11) (12) . Hippocampus is connected by neuronal projections to some (full line) but not all (dashed line) of these areas. In contrast, the hypothalamus, which is connected to the hippocampus, does not express IL-1 and TNF␣. Thus, some, but not all, neuronal projections can serve as pathways for cytokine signal propagation.
rons, whatever the neurotransmitters they produce, are capable of synthesizing IL-1 and TNF␣ under certain conditions. 35 For example, long-term potentiation (LTP) elicited by high-frequency tetanic stimulation of the CA1 area of rat hippocampus in vivo, increases IL-1␤ mRNA in the stimulated but not contralateral site. 90 This effect is likely mediated by NF-B, because LTP upregulates both subunits of NF-B and downregulates I-B.
91 I-B dissociates from NF-B, NF-B, translocates to the nucleus and induces IL-1 and TNF␣ gene expression. Thus, sustained increases in the activity of a discrete neuronal population can directly upregulate cytokine expression. This suggests that neuronal projections are a likely pathway for the propagation of cytokine signals. However, early expression of IL-1 and TNF␣ in the striatum, including the dorsal part which is not directly connected to the hippocampus, and the later expression in the cerebellum, renders the interpretation of propagation via neuronal projections incomplete (Figures 1 and 4) . Propagation via neuronal projections and/or diffusion through parenchyma or CSF is not completely compatible with the topographic distribution of cytokine-expressing neurons after the lesion to the hippocampus. This suggests that cytokine signals propagate via other pathways in addition to neuronal projections and CSF.
Propagation via gap junctions
One of these pathways may involve gap junctions connecting glial cells. The best understood are gap junctions conducting Ca 2+ flow through astrocyte networks. An increase in intracellular Ca 2+ (exceeding a cell's capacity to buffer Ca 2+ ), glutamate, 5HT, etc, can trigger, in astrocytes in vitro, oscillatory flux of Ca 2+ ions that spreads through permeable gap junctions from cell to cell in waves. 92 Firing of glutamatergic neuronal afferents in slices of rat hippocampus triggers astrocytic Ca 2+ waves. 93 The hippocampal surgical lesion activating neurons locally hence distally may have similar effects. Moreoever, Glu-induced Ca 2+ oscillations and interceullular Ca 2+ waves are dramatically increased in astrocytes affected by epileptic seizures. Astrocytes from hyperexcitable para hippocampus compared to other hippocampal areas (from individuals suffering from medically intractable epilepsy) exhibit increased gap junction coupling. 94 Glutamatergic afferents in hippocampal organotypic cultures can trigger Ca 2+ waves in astrocytes with latencies as short as 2 s. 93 The waves propagate within and between astrocytes at velocities of 7-27 m s −1 (at 21°C). They may travel as far as several cm and last many seconds. 95 Astrocytes differ in number of gap junctions depending on brain region: cerebellum Ͼ hippocampus Ͼ hypothalamus Ͼ cortex. 96 Ca 2+ waves may spread from astrocytes to other cell types via heterotypic coupling. 97 Heterotypic coupling is apparently 'chemically rectifying' ie anisotropic. Ca 2+ ions move from astrocytes into other cell types but not vice versa, because of the asymmetry of heterotypic gap junctions. 97 Thus, anisotropic propagation of cytokine signals is compatible with propagation via Ca 2+ waves.
Ca 2+ affects astrocyte function, which in turn may affect neuronal activity. Neurons in the CA1 area of the hippocampus of GFAP null mice display enhanced LTP 98 suggesting that astrocytes participate in LTP. Another example is that of axotactin, a protein secreted by glial cells during the development that ends up in neurons of Drosophila. 99 If this protein is genetically deleted and ambient temperature is reduced, then the mutant flies become paralyzed for lack of neurotransmission. Thus, astrocytes in regions distant from the initial perturbation altered by Ca 2+ waves, could affect electrophysiological activity of neurons. Perturbation of hippocampal neurons may propagate via Ca 2+ waves through the astrocyte network, change electrophysiological activity of neurons in striatum and thereby induce IL-1␣ and TNF␣ expression there. This attractive but speculative idea needs to be tested.
Cytokine cascades
IL-1 and TNF␣ induce cytokine cascades by stimulating synthesis of self, each other, other cytokines and some diffusible second messengers in autocrine and paracrine manners, as in systemic tissue. 100, 101 Exogenous IL-1␤ stimulates the synthesis of self in cultured human microglia and astrocytes. 23 It also stimulates synthesis of TNF␣, IL-6, GM-CSF 102 and TGF-␤1 15 in cultured glia. Microinfusion of IL-1␤ into the cerebral ventricle (to pathophysiological concentrations) increases concentration of mRNAs coding for the entire IL-1 cytokine family, TNF␣ and TGF-␤1. 103 Endogenous IL-1␤ induces IL-6 104 to cause fever in rodent brain. 105 IL-1 and TNF␣ also induce COX2 and NOS. Inhibiting these enzymes abrogates physiological actions of exogenous IL-1 and TNF␣ such as changes in sleep and body temperature. For example, prostaglandin inhibitors abrogate fever induced by IL-1␤ and IL-6. [106] [107] [108] Systemic injection of LPS leads to the synthesis of iNOS and COX2 mRNA in cells of the BBB. 51, 52, [109] [110] [111] [112] Inhibition of these enzymes attenuates fever, activates c-Fos expression in the brainstem and hypothalamus and activates the HPA axis (upon systemic injection of LPS or IL-1␤). 79, [113] [114] [115] [116] [117] Injection of IL1Ra, prostaglandin or NO synthesis inhibitors into the OVLT attenuates IL-1␤ induced fever. 61 These data suggest that prostaglandins and NO produced in OVLT propagate cytokine signal into the brain parenchyma causing fever and neuroendocrine activation. Thus, cytokine signals propagate through the brain by molecular cascades. Cascades regulating body temperature, sleep and, perhaps, LTP have been proposed but their precise make up needs to be further elucidated ( Figure 5 ).
Discussion and conclusions
IL-1 and TNF␣ are upregulated or induced in the brain by both central and systemic perturbations. Upregulation/induction of IL-1 and TNF␣ propagates through the brain. Cytokine signal propagation spreads along neuronal projections and extracellular diffusion Molecular Psychiatry pathways and is subsumed by molecular cascades. The propagation of cytokine signals through the brain is important because it occurs in several major brain diseases/disorders. These diseases/disorders drastically differ from each other in etiology, pathophysiology and symptomatology. Thus, the propagation of cytokine signals through the brain may be a cardinal feature of the brain's response to disease. This is consistent with the disease-associated changes in cytokine-mediated processes such as sleep, fever, sickness behavior, etc.
The data reviewed here suggest that systemic and central stimuli elicit signal propagation in distinct spatio-temporal patterns. Signals elicited by systemic stimuli propagate across the entire BBB in minutes, sequentially and transiently activating specific cell types and populations but ultimately reaching a limited brain area. In contrast, signals elicited by central stimuli propagate through the parenchyma in days but can involve a very large brain area. Distinct central stimuli originating in the same brain region (eg hippocampal seizure or surgical lesion) elicit patterns that are roughly similar to each other. Thus, spatio-temporal patterns of cytokine signal propagation may be determined, at least in part, by where the signals originate. The data suggest that all cell types in the brain can synthesize cytokines but actually do so in cell type-specific manner. Neurons and non-neuronal cells appear to propagate central and systemic signals, respectively. This distinction is further refined to reflect the nature of the eliciting signal and ensure the appropriate response.
Cytokines may be cell bound or diffusing to act in autocrine and paracrine manner, respectively. They trigger molecular cascades by inducing themselves, other cytokines and diffusible second messengers. A 'canonical cascade' may represent a prototypic mechanism of cytokine signaling in the brain ( Figure 5 ). It suggests that a cytokine signal can simultaneously propagate by several mechanisms whether or not the cytokine's receptors are on adjacent or distant cells. One cascade is complex enough but simultaneous cascades are enormously complex because they can be neutral, antagonistic or synergistic with each other. They are ordered in space and time, inter-and intracellular, transient (when regulated) or chronic (when dysregulated). They ultimately change concentration of IL-1, TNF-␣ and molecules controlling their activity, at distant sites. This change is timed to provide cytokine activity in a specific spatio-temporal pattern (eg in striatum 24 h and hippocampus 9 days after a surgical lesion). IL-1-and TNF␣-elicited molecular cascades were proposed to form autocrine-paracrine-juxtacrine feedback systems within the brain. 11 These systems are thought to have at least two components: an autoregulatory positive and negative feedback subsystems. Organisms likely compensate for loss of any one system by relying on parallel interweaving cascades. 118 The complexity suggested here, if true, enormously confounds the interpretation of most, if not all reported data, because they usually do not account for changes Molecular Psychiatry in concentration of more than a few cytokines at few time points. Novel molecular techniques such as DNA microarrays, are opening the doors to simultaneously measuring changes in gene expression of tens of thousands of cytokines and related proteins. This will inform our understanding of cytokine cascades but will not inform us about biological actions of the produced cytokines. Nevertheless, as the dynamic of cytokines' gene expression is being understood, our appreciation for the actions of cytokines in the brain will increase.
The emerging picture suggests that cytokine expression in the brain serves a fundamental need for integration of molecular and cellular activities. For the cytokines' main job in the nervous, as in the immune, system is to elicit and integrate cellular responses to perturbations. The purpose of the propagation may be to integrate the activities of various brain centers and ensure coordination of humoral and autonomic responses throughout the organism. Thus, we need to further investigate how and why cytokine signals propagate through the brain.
